Paysign PAYS Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Other Revenue | $2.52M+36.2% | $1.85M+45.7% | $1.27M+340% | $288.89K+56.3% | |
| Pharma Industry | $33.89M+168% | $12.65M+212% | $4.05M— | —— | |
| Plasma Industry | $45.62M+4.0% | $43.88M+4.6% | $41.95M+20.8% | $34.74M+34.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Paysign break its business down?
- Paysign (PAYS) reports revenue by product across 3 parts — Other Revenue, Pharma Industry and Plasma Industry. Each is extracted from the segment footnotes and tracked over time.
- Where does Paysign's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Paysign's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
